Navigation Links
State Regulation of Massage Therapy Will Improve Public Health, Safety
Date:8/5/2009

i>Toni L. Felice, public member, Butler County
  • Susan Gobreski, public member, Philadelphia County
  • Robert C. Jantsch, chairman, professional member, Allegheny County
  • Martha Kollar Malina, vice chairwoman, professional member, Dauphin County
  • Donna K. Ponessa, professional member, Lancaster County
  • William F. Vogel, professional member, Allegheny County.
  • An additional professional member will be appointed in the near future, and the Department of Health expects to name its designee shortly.

    One means of obtaining a license is completion of at least 600 hours of in-class, postsecondary massage education. The education must include training about HIV and related risks, along with cardiopulmonary resuscitation techniques. The act also requires applicants to pass a national examination.

    A provision of the act "grandfathers" existing practitioners, though they must have been in active practice for at least five years and demonstrated competence to practice.

    All licensees are required to complete at least 24 hours of continuing professional education every two years.

    The licensure law restricts use of the titles "licensed massage therapist," "massage therapist," and the abbreviation "L.M.T." to licensed massage therapists only; it also prohibits holding oneself out to others as a massage therapist without licensure. This restriction includes advertising as a massage therapist and using any title or description including massage therapist, massage practitioner, masseur, masseuse, myotherapist or any derivative of these terms.

    The act generally prohibits licensure of individuals who have been convicted of felonies under the Controlled Substance Act. It also authorizes the board to refuse, suspend or revoke a license if the licensee is convicted of a crime of moral turpitude
    '/>"/>

    SOURCE Pennsylvania Department of State
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine news :

    1. 4th Annual Case for Inclusion Report Ranks All 50 States on Community-Based Support
    2. YMCA of the USA Announces 16 Communities Selected for Statewide Policy Change Initiative to Reverse the Childhood Obesity Epidemic
    3. Multi-state Medicare Fraud Crackdown Focuses Attention on Recovery Payoffs to Defray Health Reform Costs
    4. GenVaults GenSolve(TM) Reagents Enable State-of-the-Art Genomic Analysis of Dried Blood Spots
    5. Premier of Split Estate at DocuWeeks 2009 to Call National Attention to Urban Drilling in New York and Los Angeles
    6. Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor (TNF) Blockers
    7. Ferring Pharmaceuticals Announces Trade Name FIRMAGON(R) (degarelix for injection) for Advanced Prostate Cancer Treatment
    8. K-State Researcher, Collaborators Study Virulence of Pandemic H1N1 Virus; Work at K-State Would Protect Pig Industry If the Virus Jumps to Swine Populations
    9. PracticeMatch Releases Results of Recent State of the Industry Survey of Physician Recruiters
    10. StayWell Custom Communications Partnership With HealthMedia(R) Yields State-Of-The-Art Online Health Platform
    11. Transcept Pharmaceuticals to Hold Conference Call on Agreement with Purdue Pharmaceutical Products L.P. to Commercialize Intermezzo(R) in the United States
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/18/2014)... HealthDay Reporter , THURSDAY, Sept. 18, ... common antidepressant can quickly alter the way brain cells communicate ... online Sept. 18 in Current Biology , are ... prescribed antidepressants. Experts said the hope is to eventually be ... benefit from a drug -- and which people would fare ...
    (Date:9/18/2014)... true: exercise is good for you. But new research ... have an added benefit for cancer patients undergoing chemotherapy. ... melanoma, found that combining exercise with chemotherapy shrunk tumors ... associate professor in the School of Nursing and director ... was the senior author on the study, which appears ...
    (Date:9/18/2014)... Texas (PRWEB) September 19, 2014 ... Inside the Neighborhood Mission (Misión Barrio Adentro), ... of the healthcare system (see Section 6.1.3.). ... billion) in an Autonomous Service of Pharmaceutical ... production plant, which provides medicines at a ...
    (Date:9/18/2014)... (PRWEB) September 18, 2014 Thousands of ... be recognizing their shared fundraising impact on 127 member ... 25. , The first-ever Dance Marathon Day will officially ... million projected to be raised by college and high ... Hospital. Donations generated through Dance Marathon campus programs help ...
    (Date:9/18/2014)... 18, 2014 Ben Quirk, CEO of ... Jr. Leadership Award by the Savannah Science Seminar in ... wellness throughout the nation and especially in Savannah. , ... said Ben. “The Savannah Science Seminar is an amazing ... multiple generations have gone through the program,” he added. ...
    Breaking Medicine News(10 mins):Health News:One Dose of Antidepressant Changes Brain Connections, Study Says 2Health News:One Dose of Antidepressant Changes Brain Connections, Study Says 3Health News:Exercise boosts tumor-fighting ability of chemotherapy, Penn team finds 2Health News:Venezuela Pharmaceutical Market worth $22.2 billion with 12% CAGR by 2020 Says a New Report Available at MarketOptimizer.org 2Health News:Venezuela Pharmaceutical Market worth $22.2 billion with 12% CAGR by 2020 Says a New Report Available at MarketOptimizer.org 3Health News:Venezuela Pharmaceutical Market worth $22.2 billion with 12% CAGR by 2020 Says a New Report Available at MarketOptimizer.org 4Health News:250 Campuses Usher in School Year of Saving Kids’ Lives During First-Ever “Dance Marathon Day” on Sept. 25 2Health News:Quirk Awarded the Alex Ormond, Jr. Leadership Award by the Savannah Science Seminar 2
    ... arms to snip away tumors , TUESDAY, Dec. 18 ... promise in the removal of cancer involving the tonsils, ... University of Pennsylvania, the transoral robotic surgery (TORS) system ... with an endoscope, an optical instrument with two video ...
    ... in the December issue of The Journal of the ... cancer operations in 80-year-olds are considerably worse than reported ... lead to unrealistic expectations about the safety of these ... patients and their physicians may have difficulty accurately assessing ...
    ... Calif., Dec. 18 BioMarin,Pharmaceutical Inc. (Nasdaq and ... Canadian rights for tetrahydrobiopterin (BH4), including,Kuvan(TM) (sapropterin dihydrochloride), ... Germany. Kuvan is an oral small molecule for ... Merck,Serono. Based on published literature, there are approximately ...
    ... 18 Art Mellor is one of,more than 400,000 ... from,Multiple Sclerosis (MS). It,s, a debilitating disease that causes,paralysis, ... no wonder that Mellor, the founder of the Accelerated,Cure ... and more,interested in raising the funds he needs to ...
    ... Southwestern Medical Center researchers have found that the existing body ... of obese patients at risk of cardiovascular disease. , ... Surgery for Obesity and Related Diseases, is among ... index (BMI) and cardiovascular disease as it relates to bariatric ...
    ... and Implantability Characteristics, MINNEAPOLIS, Dec. 18 ... manufacturer and marketer of state-of-the-art cardiac,surgery products ... Drug,Administration (FDA) approval for the ATS Open ... http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO ), The ATS AP360 heart ...
    Cached Medicine News:Health News:Robotic Surgery Treats Tonsil Cancer 2Health News:Study finds outcomes of high-risk cancer operations in 80-year-olds worse than reported 2Health News:BioMarin Re-Acquires Rights to Kuvan in Canada From Merck Serono 2Health News:BioMarin Re-Acquires Rights to Kuvan in Canada From Merck Serono 3Health News:BioMarin Re-Acquires Rights to Kuvan in Canada From Merck Serono 4Health News:This Holiday Season Some Dream of a White Christmas - The Accelerated Cure Project Dreams of Developing a Cure for Multiple Sclerosis 2Health News:This Holiday Season Some Dream of a White Christmas - The Accelerated Cure Project Dreams of Developing a Cure for Multiple Sclerosis 3Health News:BMI criteria for obesity surgery should be lowered, UT Southwestern researchers suggest 2Health News:ATS Medical Receives FDA Approval for AP360 Mechanical Heart Valve 2Health News:ATS Medical Receives FDA Approval for AP360 Mechanical Heart Valve 3
    (Date:9/18/2014)... Australia , Sept. 18, 2014 Veterinary ... of Dr. Ashraf Hanna , M.D., Ph.D., and ... Board of Directors. Dr. Hanna is the Vice President ... Chief Financial Officer for the Genentech Foundation, while Dr. ... Head of Business Development and Licensing for Roche Pharma. ...
    (Date:9/18/2014)... 18, 2014  Spring Bank Pharmaceuticals, Inc., a ... treatment of RNA viruses, today announced a research ... for animal testing of the Company,s lead compound, ... "Special Pathogens," against which currently there are no ... Spring Bank,s proprietary Small Molecule Nucleic Acid ...
    (Date:9/18/2014)...   Auxilium Pharmaceuticals, Inc. (NASDAQ: ... announced the first presentation of positive safety and ... Investigation of Collagenase Optimizing the Resolution of Dupuytrens) ... histolyticum (CCH) for the treatment of two Dupuytren,s ... the study examined expanded flexibility with timing of ...
    Breaking Medicine Technology:Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 2Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 3Spring Bank Pharmaceuticals Announces NIH Collaboration for Testing of SB 9200 Against Multiple Viral Pathogens 2Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 2Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 3Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 4Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 5Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 6Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 7
    Our Osteomark® ELISA kits provide a quantitative measurement of cross-linked N-telopeptides of type I collagen (NTx) as an indicator of bone resorption, with higher levels in serum or urine sampl...
    Our Osteomark® ELISA kits provide a quantitative measurement of cross-linked N-telopeptides of type I collagen (NTx) as an indicator of bone resorption, with higher levels in serum or urine sampl...
    ... Cobalt Binding (ACB®) Test is a clinical ... (IMA®) by measuring the cobalt binding capacity ... First identified in the early 1990s, IMA ... contact with ischemic tissue in the heart. ...
    Inquire...
    Medicine Products: